KDR and glioma: Post mortem histological examination of glioma bioptic specimens of patients died after receiving treatment with cediranib, an inhibitor of VEGF receptor-2 (VEGFR-2) [85], or bevacizumab [86] have shown that the glioma cells were growing around pre-existing vessels in a non-angiogenic fashion.